These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 15075020)
1. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Tozzi V; Balestra P; Murri R; Galgani S; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Fantoni M; Sampaolesi A; Noto P; Ippolito G; Wu AW Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020 [TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort. de Boer-van der Kolk IM; Sprangers MA; Prins JM; Smit C; de Wolf F; Nieuwkerk PT Clin Infect Dis; 2010 Jan; 50(2):255-63. PubMed ID: 20014949 [TBL] [Abstract][Full Text] [Related]
4. Is quality of life associated with cognitive impairment in schizophrenia? Alptekin K; Akvardar Y; Kivircik Akdede BB; Dumlu K; Işik D; Pirinçci F; Yahssin S; Kitiş A Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):239-44. PubMed ID: 15694230 [TBL] [Abstract][Full Text] [Related]
5. Neurocognitive performance and quality of life in patients with HIV infection. Tozzi V; Balestra P; Galgani S; Murri R; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Costa M; Sampaolesi A; Fantoni M; Noto P; Ippolito G; Wu AW AIDS Res Hum Retroviruses; 2003 Aug; 19(8):643-52. PubMed ID: 13678465 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. Siddiqui U; Bini EJ; Chandarana K; Leong J; Ramsetty S; Schiliro D; Poles M J Clin Gastroenterol; 2007; 41(5):484-90. PubMed ID: 17450031 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825 [TBL] [Abstract][Full Text] [Related]
8. Poor health-related quality of life and abnormal psychosocial adjustment in Italian children with perinatal HIV infection receiving highly active antiretroviral treatment. Bomba M; Nacinovich R; Oggiano S; Cassani M; Baushi L; Bertulli C; Longhi D; Coppini S; Parrinello G; Plebani A; Badolato R AIDS Care; 2010 Jul; 22(7):858-65. PubMed ID: 20635250 [TBL] [Abstract][Full Text] [Related]
9. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256 [TBL] [Abstract][Full Text] [Related]
10. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection. Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM; Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958 [TBL] [Abstract][Full Text] [Related]
11. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART. Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516 [TBL] [Abstract][Full Text] [Related]
12. Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection. Powers AE; Marden SF; McConnell R; Leidy NK; Campbell CM; Soeken KL; Barker C; Davey RT; Dybul MR AIDS; 2006 Apr; 20(6):837-45. PubMed ID: 16549967 [TBL] [Abstract][Full Text] [Related]
13. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. Mast TC; Kigozi G; Wabwire-Mangen F; Black R; Sewankambo N; Serwadda D; Gray R; Wawer M; Wu AW AIDS Care; 2004 Jan; 16(1):81-94. PubMed ID: 14660146 [TBL] [Abstract][Full Text] [Related]
14. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK; AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495 [TBL] [Abstract][Full Text] [Related]
15. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment]. Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008 [TBL] [Abstract][Full Text] [Related]
16. Determinants of health-related quality of life in HIV-infected patients. Murri R; Fantoni M; Del Borgo C; Visona R; Barracco A; Zambelli A; Testa L; Orchi N; Tozzi V; Bosco O; Wu AW AIDS Care; 2003 Aug; 15(4):581-90. PubMed ID: 14509872 [TBL] [Abstract][Full Text] [Related]
17. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis. Piccinni A; Maser JD; Bazzichi L; Rucci P; Vivarelli L; Del Debbio A; Catena M; Bombardieri S; Dell'Osso L Compr Psychiatry; 2006; 47(3):201-8. PubMed ID: 16635649 [TBL] [Abstract][Full Text] [Related]
19. Depression and neurocognitive performance in Portuguese patients infected with HIV. Bragança M; Palha A AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031 [TBL] [Abstract][Full Text] [Related]
20. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City. Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]